Why the study?
Does myocardial perfusion scintigraphy improve the diagnostic and functional categorization of patients with acute and chronic coronary disease compared to electrocardiography alone?
Does myocardial perfusion scintigraphy improve the diagnostic and functional categorization of patients with acute and chronic coronary disease compared to electrocardiography alone?
Myocardial perfusion scintigraphy provides critical diagnostic and prognostic information that overcomes the limitations of standard electrocardiography in coronary disease.
Answers are grounded in this paper and cite their sources.
May aid MI and ischemia categorization beyond ECG; leaves open prospective outcome trials before practice change.
In summary, myocardial perfusion scintigraphy with either thallium or the isonitriles has added substantially to electrocardiographic definition of both myocardial infarction and acute and chronic myocardial ischemia. Using perfusion scintigraphy, one can define infarct zones, risk zones, and the presence of reperfusion following thrombolytic therapy. When perfusion scintigraphy is combined with physiologic or pharmacologic stress, myocardial ischemia can be documented, irrespective of electrocardiographic documentation of the phenomenon. Delayed imaging may be important for defining viability even in the presence of significant Q waves. Myocardial perfusion scintigraphy provides prognostic evaluation of patients with both acute and chronic coronary syndromes. When the current cumulative experience is looked at critically, it is clear that myocardial perfusion scintigraphy has helped in the development of an understanding of the limitations of electrocardiography in the diagnostic and functional categorization of patients with acute and chronic coronary disease.
No takes yet. Share an insight, caveat, or question.
Zaret et al. (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: